Vascular Pleiotrophic Effects of Bisphosphonates in Post Menopausal Women with Osteoporosis: Cellular Mechanisms and Functional Consequences.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Risedronic acid (Primary)
- Indications Cardiovascular disorders; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 18 Aug 2011 New trial record